MR angiography with an ultrasmall superparamagnetic iron oxide blood pool agent

Journal of Magnetic Resonance Imaging

Volumn 7, Issue 1, 1997, Pages 209-214

  Anzai, Yoshimi ^a   Prince, Martin R ^a   Chenevert, Thomas L ^a   Maki, Jeffrey H ^a   Londy, Frank ^a   London, Manette ^a   McLachlan, Stuart J ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b Advanced Magnetics Inc   (United States)

Author keywords

Contrast agent; Iron oxide; MR angiography; MR imaging

Indexed keywords

ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG;

ABDOMINAL ANGIOGRAPHY; ADULT; ARTICLE; BLOOD VESSEL; BREATH HOLDING; CONTRAST ENHANCEMENT; FEMALE; HUMAN; HUMAN EXPERIMENT; IMAGE ANALYSIS; IMAGE QUALITY; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; PRIORITY JOURNAL; SIGNAL NOISE RATIO;

ABDOMEN; ADULT; ANGIOGRAPHY; CONTRAST MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; FEASIBILITY STUDIES; FEMALE; FERRIC COMPOUNDS; HALF-LIFE; HUMANS; INJECTIONS, INTRAVENOUS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; PHLEBOGRAPHY; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; THORAX;

EID: 0031412997     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.1880070132     Document Type: Article

References (19)

1. Prince MR, Yucel EK, Kaufman JA, Harrison DC, Geller SC. Dynamic gadolinium-enhanced three-dimensional abdominal MR arteriography. J Magn Reson Imaging 1993; 3(6):877-881.
2. Edelman RR. Magnetic resonance angiography. An overview. Invest Radiol 1993; 28(4):43-46.
3. Prince MR. Gadolinium-enhanced MR aortography. Radiology 1994; 191(1):155-164.
4. Prince MR, Narasimham DL, Stanley JC, et al. Breath-hold gadolinium-enhanced MR angiography of the abdominal aorta and its major branches. Radiology 1995; 197(3):785-792.
5. Douek PC, Revel D, Chazel S, Falise B, Villard J, Amiel M. Fast MR angiography of the aortoiliac arteries and arteries of the lower extremity: value of bolus-enhanced, whole-volume subtraction technique. AJR 1995; 165(2):431-437.
6. Prince MR, Narasimham DL, Stanley JC, et al. Gadolinium-enhanced magnetic resonance angiography of abdominal aortic aneurysms. J Vasc Surg 1995; 21(4):656-669.
7. Snidow JJ, Aisen AM, Harris VJ, et al. Iliac artery MR angiography: comparison of three-dimensional gadolinium-enhanced and two-dimensional time-of-flight techniques. Radiology 1995; 196:371-378.
8. Davis CP, Ladd ME, Romanowski BJ, Wildermuth S, Knoplioch JF, Debatin JF. Human aorta: preliminary results with virtual endoscopy based on three-dimensional MR imaging data sets. Radiology 1996; 199:37-40.
9. Bourne MW, Margerun L, Hylton N, et al. Evaluation of the effects of intravascular MR contrast media (gadolinium dendrimer) on 3D time of flight magnetic resonance angiography of the body. JMRI 1996; 6:305-310.
10. McLachlan SJ, Morris MR, Lucas MA, et al. Phase I clinical evaluation of a new iron oxide MR contrast agent. JMRI 1994; 4:301-307.
11. Siani S, Edleman RR, Sharma P, et al. Blood-pool MR contrast material for detection and characterization of focal hepatic lesions: initial clinical experience with ultrasmall superparamagnetic iron oxide (AMI-227). AJR 1995; 164(5):1147-1152.
12. Vassallo P, Matei C, Heston WDH, McLachlan SJ, Koutcher JA, Castellino RA. USPIO-enhanced MR lymphography: usefulness for differentiating reactive from tumor-bearing lymph nodes. Radiology 1994; 193:501-506.
13. Anzai Y, McLachlan S, Saxton R, Moris M, Lufkin RB. Dextran-coated superparamagnetic iron oxide: the first human use of a new MR contrast agent for assessing lymph nodes in the head and neck. AJNR 1994; 15:87-94.
14. Anzai Y, Blackwell K, Hirschowitz S, et al. Initial clinical experience with dextran-coated superparamagnetic iron oxide for detection of lymph node metastases in patients with head and neck cancer. Radiology 1994; 192(3):709-715.
15. Frank H, Weissleder R, Brady TJ. Enhancement of MR angiography with iron oxide: preliminary studies in whole blood phantom and in animals. AJR 1994; 162:209-213.
16. Mayo-Smith WW, Saini S, Slater G, Kaufman JA, Sharma P, Hahn PF. MR contrast material for vascular enhancement: value of superparamagnetic iron oxide. AJR 1996; 166(1):73-77.
17. Stillman AE, Wilke N, Li D, Haacke M, McLachlan S. Ultrasmall superparamagnetic iron oxide to enhance MRA of the renal and coronary arteries: studies in human patients. J Comput Assist Tomogr 1996; 20(1):51-55.
18. Jung CW, Jacobs P. Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil. Magn Reson Imaging 1995; 13(5):661-674.
19. Jung CW. Surface properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil. Magn Reson Imaging 1995; 13(5):675-691.